http://www.unboundmedicine.com/medline/ebm/research/decitabineUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19882154/full_citation/Generation_of_antigen_presenting_cells_from_tumor_infiltrated_CD11b_myeloid_cells_with_DNA_demethylating_agent_5_aza_2'_deoxycytidine_Daurkin I, Eruslanov E, Vieweg J, et al. 
Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine. [JOURNAL ARTICLE]
Cancer Immunol Immunother 2009 Oct 31.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19854495/full_citation/Epigenetic_therapies_for_chemoresensitization_of_epithelial_ovarian_cancer_Matei DE, Nephew KP 
Epigenetic therapies for chemoresensitization of epithelial ovarian cancer. [JOURNAL ARTICLE]
Gynecol Oncol 2009 Oct 23.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19850902/full_citation/Decitabine_versus_5_azacitidine_for_the_treatment_of_myelodysplastic_syndrome:_adjusted_indirect_meta_analysis_Kumar A, List AF, Hozo I, et al. 
Decitabine versus 5-azacitidine for the treatment of myelodysplastic syndrome: adjusted indirect meta-analysis. [JOURNAL ARTICLE]
Haematologica 2009 Oct 22.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19842938/full_citation/Genetic_factors_influencing_cytarabine_therapy_Lamba JK 
Genetic factors influencing cytarabine therapy. [Journal Article]
Pharmacogenomics 2009 Oct; 10(10):1657-74.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19840838/full_citation/The_effect_of_dietary_polyphenols_on_the_epigenetic_regulation_of_gene_expression_in_MCF7_breast_cancer_cells_Paluszczak J, Krajka-Kuźniak V, Baer-Dubowska W 
The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. [JOURNAL ARTICLE]
Toxicol Lett 2009 Oct 16.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19837153/full_citation/Effects_of_decitabine_on_the_expression_of_selected_endogenous_control_genes_in_human_breast_cancer_cells_Kastl L, Brown I, Schofield AC 
Effects of decitabine on the expression of selected endogenous control genes in human breast cancer cells. [JOURNAL ARTICLE]
Mol Cell Probes 2009 Oct 15.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19818596/full_citation/Regulation_of_EP_receptors_in_non_small_cell_lung_cancer_by_epigenetic_modifications_Gray SG, Al-Sarraf N, Baird AM, et al. 
Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications. [JOURNAL ARTICLE]
Eur J Cancer 2009 Oct 7.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19808971/full_citation/Azacytidine_inhibits_RNA_methylation_at_DNMT2_target_sites_in_human_cancer_cell_lines_Schaefer M, Hagemann S, Hanna K, et al. 
Azacytidine inhibits RNA methylation at DNMT2 target sites in human cancer cell lines. [Journal Article, Research Support, Non-U.S. Gov't]
Cancer Res 2009 Oct 15; 69(20):8127-32.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19806788/full_citation/Expression_and_mutation_analysis_of_TIG1__tazarotene_induced_gene_1__in_human_gastric_cancer_Son MS, Kang MJ, Park HC, et al. 
Expression and mutation analysis of TIG1 (tazarotene-induced gene 1) in human gastric cancer. [Journal Article, Research Support, Non-U.S. Gov't]
Oncol Res 2009; 17(11-12):571-80.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19795507/full_citation/Superior_outcome_with_hypomethylating_therapy_in_patients_with_acute_myeloid_leukemia_and_high_risk_myelodysplastic_syndrome_and_chromosome_5_and_7_abnormalities_Ravandi F, Issa JP, Garcia-Manero G, et al. 
Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities. [JOURNAL ARTICLE]
Cancer 2009 Sep 30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles